Retrieve available abstracts of 16 articles: HTML format
Single Articles
May 2025
SELMAN M, Buendia-Roldan I, Pardo A Decoding the complexity: mechanistic insights into comorbidities in idiopathic
pulmonary fibrosis.
Eur Respir J. 2025;65:2402418. PubMedAbstract available
March 2025
RATSIHORIMANANA R, Maitre T, Dusselier M, Triet Ngo M, et al Recurrent respiratory papillomatosis in adults with lower respiratory tract
involvement: a retrospective study of the OrphaLung and GETIF networks.
Eur Respir J. 2025;65:2400618. PubMedAbstract available
December 2024
WENG C, Zhao Y, Song M, Shao Z, et al Mosaic loss of chromosome Y, tobacco smoking and risk of age-related lung
diseases: insights from two prospective cohorts.
Eur Respir J. 2024;64:2400968. PubMedAbstract available
November 2024
YOON HY, Kim H, Bae Y, Song JW, et al Pirfenidone and risk of lung cancer development in IPF: a nationwide
population-based study.
Eur Respir J. 2024 Nov 7:2401484. doi: 10.1183/13993003.01484-2024. PubMedAbstract available
June 2024
D'AMOURS MF, Wu FTH, Theisen-Lauk O, Chan EK, et al Surgically Resectable Non-Small Cell Lung Cancer: A Contemporary Approach.
Eur Respir J. 2024 Jun 6:2400332. doi: 10.1183/13993003.00332-2024. PubMedAbstract available
SEIJO LM, Zulueta JJ The tip of the iceberg: a plethora of lung nodules in the general population.
Eur Respir J. 2024;63:2400889. PubMed
CAI J, Vonder M, Du Y, Pelgrim GJ, et al Who is at risk of lung nodules on low-dose CT in a Western country? A
population-based approach.
Eur Respir J. 2024;63:2301736. PubMedAbstract available
PORCEL JM Pleural mesothelioma: surgery questioned again?
Eur Respir J. 2024;63:2400896. PubMed
RASKIN J, Surmont V, Maat APWM, Yahia M, et al A randomised phase II study of extended pleurectomy/decortication preceded or
followed by chemotherapy in patients with early-stage pleural mesothelioma: EORTC
1205.
Eur Respir J. 2024;63:2302114. PubMedAbstract available
May 2024
SESE L, Annesi-Maesano I Lung cancer and idiopathic pulmonary fibrosis: environmental exposures are the
key.
Eur Respir J. 2024;63:2400760. PubMed
April 2024
BRUDON A, Legendre M, Mageau A, Bermudez J, et al High risk of lung cancer in surfactant-related gene variant carriers.
Eur Respir J. 2024 Apr 4:2301809. doi: 10.1183/13993003.01809-2023. PubMedAbstract available
LEWIS KE Smoking cessation at lung cancer screening: joining (life-saving) dots.
Eur Respir J. 2024;63:2400550. PubMed
March 2024
YOON HY, Kim SY, Song JW Association Between High Levels of Nitrogen Dioxide and Increased Cumulative
Incidence of Lung Cancer in Patients with Idiopathic Pulmonary Fibrosis.
Eur Respir J. 2024 Mar 7:2301181. doi: 10.1183/13993003.01181-2023. PubMedAbstract available
February 2024
"ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings
from low dose CT screening for lung cancer." E.L. O'Dowd, I. Tietzova, E.
Bartlett, et al. Eur Respir J 2023; 62: 2300533.
Eur Respir J. 2024;63:2350533. PubMed
January 2024
OBACZ J, Valer JA, Nibhani R, Adams TS, et al Single-cell transcriptomic analysis of human pleura reveals stromal heterogeneity
and informs in vitro models of mesothelioma.
Eur Respir J. 2024;63:2300143. PubMedAbstract available
October 2023
O'DOWD EL, Tietzova I, Bartlett E, Devaraj A, et al ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from
low dose CT screening for lung cancer.
Eur Respir J. 2023 Oct 6:2300533. doi: 10.1183/13993003.00533-2023. PubMedAbstract available